ArticleCureus2026
Single-Nucleotide Polymorphism (SNP) A986S (rs1801725) of the Calcium-Sensing Receptor in Children With Idiopathic Hypercalciuria.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Idiopathic hypercalciuria (IH) is a common metabolic abnormality in children and an important risk factor for hematuria, nephrolithiasis, and recurrent urinary symptoms. Genetic factors, particularly variations in the calcium-sensing receptor (CaSR) gene, may predispose individuals to altered calcium homeostasis. The CaSR A986S polymorphism (rs1801725) has been implicated in abnormal calcium metabolism and stone disease, but evidence in pediatric populations remains limited. Objective To investigate the association between the CaSR A986S (rs1801725) polymorphism and IH in children. Methods A case-control study was conducted at a tertiary nephrology center in Bangalore between January 2022 and May 2023. Sixty children aged 4-14 years with IH were compared with 60 age- and sex-matched controls. Clinical characteristics, serum calcium levels, and 24-hour urinary calcium excretion were assessed. Genotyping for rs1801725 (A986S) was performed, and genotype frequencies, p-values, and ORs were calculated using SPSS software. Results Children with IH had significantly higher 24-hour urinary calcium excretion than controls (413 ± 76 vs 215 ± 132 mg/day; p = 0.001). The mutant TT genotype was more frequent in patients with IH than in controls (15% vs 1.7%; p = 0.02), while the normal GG genotype was significantly less common in patients with IH (60% vs 91%; p = 0.0002). Allelic analysis showed a significantly higher frequency of the T allele in patients with IH (35% vs 5%), conferring a markedly increased risk of IH (OR = 10.23; 95% CI: 2.85-36.66; p = 0.0004). Conclusion The CaSR A986S (rs1801725) polymorphism is significantly associated with IH in children. The T allele, particularly the TT and GT genotypes, confers a markedly increased risk of IH, suggesting a meaningful genetic contribution to calcium dysregulation in the pediatric population. These findings support the potential role of CaSR genotyping in early risk stratification and individualized management of IH.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.